QuantumSi (NASDAQ: QSI) — Perfil da empresa, notícias e dados financeiros
QuantumSi is pioneering semiconductor chip-based proteomics, aiming to enhance disease diagnosis and treatment through innovative technology.

QuantumSi
QuantumSi (NASDAQ:QSI) is focused on pioneering next-generation semiconductor chip-based proteomics. This technology-driven company aims to revolutionize how the healthcare industry understands and utilizes proteins to diagnose and treat diseases. By developing a unique platform that leverages the power of semiconductors to read proteins, QuantumSi endeavors to unlock a deeper understanding of the molecular underpinnings of health. With projects that range from improving disease detection to facilitating personalized medicine, the company's objectives are centered on enabling advancements in medical research and patient care through their innovative approach to proteomics. QuantumSi’s efforts are squarely aimed at transforming healthcare outcomes by providing critical insights that were previously unattainable, ensuring a pivotal role in the future of medicine.
Resumo
Operações
Produtos e/ou serviços de QuantumSi
- Protein sequencing platform: Revolutionizes proteomics by enabling real-time protein sequencing.
- End-to-end solutions: Offers comprehensive services from sample preparation to data analysis.
- Single-molecule detection: Advanced technology for detecting and analyzing individual protein molecules.
- Compact sequencer devices: Designs portable sequencing devices for wider accessibility.
- Software suite: Provides robust data analysis and management software for sequencing results.
- Custom assay development: Works with researchers to develop bespoke assays tailored to specific research needs.
equipe executiva do QuantumSi
- Jeffrey Alan HawkinsPresident, CEO & Director
- Jonathan M. RothbergFounder & Executive Director
- Jeffry R. KeyesCFO & Treasurer
Últimas notícias sobre a QuantumSi
Principais indicadores financeiros
Resultados divulgados pela QuantumSi, em USD.
- Cap. de mercado
- 361,2 mi
- Receita (TTM)
- 1,6 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.5
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 2,4 mi | -97,4 mi | -101,3 mi | |
| 3,1 mi | -108,6 mi | -101 mi | |
| 1,1 mi | -111,2 mi | -96 mi | |
| 459 mil | -123,8 mi | -132,4 mi |